Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 18 (Search time: 0.003 seconds).
Issue DateTitleAuthor(s)
2013Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?MIRANDA, Vanessa Costa; DIB-FARIA, Luiza; BRAGHIROLI, Maria Ignez Freitas Melro; SABBAGA, Jorge; SARAGIOTTO, Daniel Fernandes; CASTRO, Gilberto; HOFF, Paulo M.; RIECHELMANN, Rachel
2019Cachexia in head and neck squamous cell carcinoma (HNSCC) patients (pts) after cisplatin-based chemoradiation (CRT): A cross-sectional study.CASTRO, Gilberto; NEVES, Willian das; RIVELLI, Thomas Giollo; SIMAO, Eduardo Furquim; MARTINS, Renata Eiras; KULCSAR, Marco Aurelio Vamondes
2019Synchronous esophageal cancer impact on survival of head and neck squamous cell carcinoma (HNSCC) patients.DIVINO, Paulo Henrique Amor; MATOS, Gustavo Duarte Ramos; LIMA, Karolina; CASTRO, Gilberto; MARTA, Gustavo Nader; TAKEDA, Flavio Roberto; CECCONELLO, Ivan; BRAGHIROLI, Oddone Freitas Melro; MAK, Milena Perez
2019The ideal amount of physical activity to improve quality of life and symptoms in lung cancer patients: A systematic review.CASTRO, Gilberto; CODIMA, Alberto; NEVES, Willian das; BORGES, Ana Paula Souza
2019The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).PAZ-ARES, Luis G.; GARON, Edward B.; ARDIZZONI, Andrea; BARLESI, Fabrice; CHO, Byoung Chul; CASTRO, Gilberto; MARCHI, Pedro De; FELIP, Enriqueta; GOTO, Yasushi; GREYSTOKE, Alastair; LU, Shun; LIM, Darren Wan Teck; PAPADIMITRAKOPOULOU, Vassiliki; RECK, Martin; SOLOMON, Benjamin J.; SPIGEL, David R.; TAN, Daniel Shao-Weng; THOMAS, Michael; YANG, James Chih-Hsin; JOHNSON, Bruce E.
2012Excision repair cross-complementary group 1 (ERCC1) as a prognostic biomarker in patients (pts) with solid tumors: A meta-analysis on detection methodsMAK, Milena Perez; TAKAHASHI, Tiago Kenji; HOFF, Paulo Marcelo; CASTRO, Gilberto; SNITCOVSKY, Igor M. L.
2017Phase II trial of valproic acid combined with cisplatin-based chemoradiation in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).MAK, Milena Perez; PASINI, Fatima Solange; DIAO, Lixia; GARCIA, Fabyane Oliveira Teixeira; TAKAHASHI, Tiago Kenji; AMADIO, Alex Vitorio; SIQUEIRA, Sheila Aparecida Coelho; SICHERO, Laura; SNITCOVSKY, Igor M. L.; KULCSAR, Marco Aurelio Vamondes; WANG, Jing; CASTRO, Gilberto
2019Safety run-in results from phase 3 study of canakinumab (CAN) or placebo in combination with pembrolizumab (PEM) plus platinum based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC (CANOPY-1)JOHNSON, Bruce E.; KIM, Tae Min; HILTERMANN, T. Jeroen N.; BARLESI, Fabrice; GROHE, Christian; GOTO, Yasushi; GUNNARSSON, Orvar; OVERBECK, Tobias; REGUART, Noemi; WERMKE, Martin; CASTRO, Gilberto; FELIP, Enriqueta; GREYSTOKE, Alastair; SOLOMON, Benjamin J.; NEBOT, Noelia; DEUDON, Stephanie; LOUVEAU, Anne-Laure; PASSOS, Vanessa Q.; TAN, Daniel S. W.
2013Cancer patients with ECOG-PS higher than 1: Who are those who benefit of palliative chemotherapy?CAIRES-LIMA, Rafael; PROTASIO, Bruno Mendonca; CAIRES, Inacelli Queiroz de Souza; ROCHA, Lucila Soares Da Silva; OLIVEIRA, Julia Andrade De; GUERRA, Raquel Bezerra; MAK, Milena Perez; HOFF, Paulo M.; CASTRO, Gilberto
2022Performance of the 2021 CKD-EPI equations without a race coefficient in a multi-racial population of adults with solid tumors: A prospective cross-sectional study.SILVA, Veronica Torres Costa E; GIL- JR., Luiz A.; INKER, Lesley; CAIRES, Renato; COSTALONGA, Elerson; COURA-FILHO, George; ESTEVEZ-DIZ, Maria Del Pilar; CASTRO, Gilberto; MATHEW, Paul; LEVEY, Andrew; BURDMANN, Emmanuel de Almeida